Azin Samimi1,2, Mohammad Javad Khodayar1,3, Hadis Alidadi1,3, Elahe Khodadi4. 1. Department of Toxicology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. 2. Legal Medicine Organization, Legal Medicine Research Center, Ahvaz, Iran. 3. Toxicology Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. 4. Thalassemia & Hemoglobinopathy Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. khodadi.e@ajums.ac.ir.
Abstract
BACKGROUND AND OBJECTIVE: Reactive oxygen species (ROS) play crucial role in hematopoiesis, regulation of differentiation, self-renewal, and the balance between quiescence and proliferation of hematopoietic stem cells (HSCs). The HSCs are a small population of undifferentiated cells that reside in the bone marrow (BM) and can undergo self-renewal by giving rise to mature cells. METHODS: Relevant literature was identified through a PubMed search (2000-2019) of English-language papers using the following terms: reactive oxygen species, hematopoietic stem cell, leukemic stem cell, leukemia and chemotherapy. RESULTS: HSCs are very sensitive to high levels of ROS and increased production of ROS have been attributed to HSC aging. HSC aging induced by both cell intrinsic and extrinsic factors is linked to impaired HSC self-renewal and regeneration. In addition, the elevated ROS levels might even trigger differentiation of Leukemic stem cells (LSCs) and ROS may be involved in the initiation and progression of hematological malignancies, such as leukemia. CONCLUSION: Targeting genes involved in ROS in LSCs and HSCs are increasingly being used as a critical target for therapeutic interventions. Appropriate concentration of ROS may be an optimal therapeutic target for treatment of leukemia during chemotherapy, but still more studies are required to better understanding of the of ROS role in blood disorders.
BACKGROUND AND OBJECTIVE: Reactive oxygen species (ROS) play crucial role in hematopoiesis, regulation of differentiation, self-renewal, and the balance between quiescence and proliferation of hematopoietic stem cells (HSCs). The HSCs are a small population of undifferentiated cells that reside in the bone marrow (BM) and can undergo self-renewal by giving rise to mature cells. METHODS: Relevant literature was identified through a PubMed search (2000-2019) of English-language papers using the following terms: reactive oxygen species, hematopoietic stem cell, leukemic stem cell, leukemia and chemotherapy. RESULTS: HSCs are very sensitive to high levels of ROS and increased production of ROS have been attributed to HSC aging. HSC aging induced by both cell intrinsic and extrinsic factors is linked to impaired HSC self-renewal and regeneration. In addition, the elevated ROS levels might even trigger differentiation of Leukemic stem cells (LSCs) and ROS may be involved in the initiation and progression of hematological malignancies, such as leukemia. CONCLUSION: Targeting genes involved in ROS in LSCs and HSCs are increasingly being used as a critical target for therapeutic interventions. Appropriate concentration of ROS may be an optimal therapeutic target for treatment of leukemia during chemotherapy, but still more studies are required to better understanding of the of ROS role in blood disorders.
Authors: Marisa M Juntilla; Vineet D Patil; Marco Calamito; Rohan P Joshi; Morris J Birnbaum; Gary A Koretzky Journal: Blood Date: 2010-03-30 Impact factor: 22.113
Authors: J E Megías-Vericat; P Montesinos; M J Herrero; F Moscardó; V Bosó; L Rojas; D Martínez-Cuadrón; R Rodríguez-Veiga; L Sendra; J Cervera; J L Poveda; M Á Sanz; S F Aliño Journal: Pharmacogenomics J Date: 2017-05-09 Impact factor: 3.550
Authors: Tugba Simsek; Fatih Kocabas; Junke Zheng; Ralph J Deberardinis; Ahmed I Mahmoud; Eric N Olson; Jay W Schneider; Cheng Cheng Zhang; Hesham A Sadek Journal: Cell Stem Cell Date: 2010-09-03 Impact factor: 24.633
Authors: Haotian Yang; Rehan M Villani; Haolu Wang; Matthew J Simpson; Michael S Roberts; Min Tang; Xiaowen Liang Journal: J Exp Clin Cancer Res Date: 2018-11-01
Authors: Sini Sunny; Arun Jyothidasan; Cynthia L David; Krishna Parsawar; Arul Veerappan; Dean P Jones; Steven Pogwizd; Namakkal S Rajasekaran Journal: Front Cardiovasc Med Date: 2022-06-13
Authors: Alvaro M Gonzalez-Ibanez; Lina M Ruiz; Erik Jensen; Cesar A Echeverria; Valentina Romero; Linsey Stiles; Orian S Shirihai; Alvaro A Elorza Journal: Front Cell Dev Biol Date: 2020-11-23